Roddy P, Dalrymple U, Jensen TO, Dittrich S, Rao VB, et al.
2019-07-25 • PLOS One
2019-07-25 • PLOS One
Severe-febrile-illness (SFI) is a common cause of morbidity and mortality across sub-Saharan Africa (SSA). The burden of SFI in SSA is currently unknown and its estimation is fraught wit...
Fajardo E, Metcalf CJ, Piriou E, Gueguen M, Maman D, et al.
2015-06-25 • Bulletin of the World Health Organization
2015-06-25 • Bulletin of the World Health Organization
OBJECTIVE To estimate the proportion of invalid results generated by a CD4+ T-lymphocyte analyser used by Médecins Sans Frontières (MSF) in field projects and identify factors associ...
Cooke GS, Andrieux-Meyer I, Applegate TL, Atun R, Burry J, et al.
2019-02-01 • Lancet Gastroenterology and Hepatology
2019-02-01 • Lancet Gastroenterology and Hepatology
Viral hepatitis is a major public health threat and a leading cause of death worldwide. Annual mortality from viral hepatitis is similar to that of other major infectious diseases such a...
Despite immense progress in antiretroviral therapy (ART) scale-up, many people still lack access to basic standards of care, with our ability to meet the Joint United Nations Programme o...
2012-10-09 • Journal of the International AIDS Society
2012-10-09 • Journal of the International AIDS Society
Though the advantages of routine virological monitoring for patients on anti-retroviral therapy have been established, cost and complexity limit its full implementation. Monitoring is im...
Cohn J, Bygrave H, Roberts TR, Khan T, Ojji D, et al.
2022-04-12 • Global Heart
2022-04-12 • Global Heart
Hypertension is the most important risk factor for cardiovascular diseases (CVDs), which are the leading global cause of death. Hypertension is under-diagnosed and under-treated in most ...
Grebely J, Bruneau J, Lazarus JV, Dalgard O, Bruggmann P, et al.
2017-07-03 • International Journal of Drug Policy
2017-07-03 • International Journal of Drug Policy
Globally, it is estimated that 71.1 million people have chronic hepatitis C virus (HCV) infection, including an estimated 7.5 million people who have recently injected drugs (PWID). Ther...
Phillips AN, Shroufi A, Vojnov L, Cohn J, Roberts TR, et al.
2015-12-01 • Nature
2015-12-01 • Nature
There are inefficiencies in current approaches to monitoring patients on antiretroviral therapy in sub-Saharan Africa. Patients typically attend clinics every 1 to 3 months for clinical ...
Peter T, Ellenberger D, Kim AA, Boeras D, Messele T, et al.
2016-10-20 • Lancet Infectious Diseases
2016-10-20 • Lancet Infectious Diseases
Scaling up access to HIV viral load testing for individuals undergoing antiretroviral therapy in low-resource settings is a global health priority, as emphasised by research showing the ...
Lynch S, Ford NP, van Cutsem G, Bygrave H, Janssens B, et al.
2012-07-20 • Science
2012-07-20 • Science
The new understanding that antiretroviral therapy (ART) can significantly reduce HIV transmission has stimulated scientific and political leaders to claim that ending the AIDS epidemic i...
Bonner K, Siemieniuk R, Boozary A, Roberts TR, Fajardo E, et al.
2014-12-01 • PLOS One
2014-12-01 • PLOS One
HIV viral load (VL) testing is the gold standard for antiretroviral treatment monitoring, but many barriers exist to VL testing in resource-limited settings, including storage and transp...
